Clinical Development Team

The Clinical Development Team at HepaRegeniX is responsible for designing and overseeing clinical trials to evaluate the safety and efficacy of new drugs targeting liver diseases. Led by the Chief Medical Officer, the team collaborates with experts in medicinal chemistry and clinical consultancy to ensure compliance with regulatory standards, optimize drug formulations, and advance innovative treatments from early-stage research to market readiness.